Muhlenkamp & Co Teva Pharma Industries Ltd ADR transactions over time
TEVA-OLD
Teva Pharma Industries Ltd ADR historical holders
total: 10
Transactions details
- Total transactions:
- 17
- New positions:
- 1
- Sold out:
- 1
- Added:
- 8
- Reduced:
- 7
- Held since:
- 2013 Q2 or earlier
- Held for:
- 19+ quarters
- Latest activity:
- 2018 Q1
Ronald Muhlenkamp has been an institutional investor in Teva Pharma Industries Ltd ADR (TEVA-OLD) since at least 2013 Q2. According to 2026 Q2 report, Ronald Muhlenkamp doesn't hold any shares. In our earliest available record from 2013 Q2, Muhlenkamp & Co held 169,660 shares of TEVA-OLD. Since at least 2013 Q2, Muhlenkamp & Co has made 16 more transactions in this position.
When did Ronald Muhlenkamp exit their TEVA-OLD position?
Ronald Muhlenkamp no longer holds Teva Pharma Industries Ltd ADR (TEVA-OLD). They sold off their entire position in 2018 Q1, closing out an investment that began in 2013 Q2.
Estimated cost basis*
- Weighted AVG buy price:
- $38.58
- Weighted AVG sell price:
- $25.75
TEVA-OLD transactions history by Muhlenkamp & Co
17 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2018 Q1
|
0.00%
|
$18.57
|
-100% (-700)
|
|||
|
2017 Q3
|
0.00%
|
$17.14
|
-99.34% (-105,805)
|
|||
|
2017 Q2
|
1.16%
|
$33.22
|
-0.13% (-140)
|
|||
|
2017 Q1
|
1.11%
|
$32.09
|
-55.54% (-133,244)
|
|||
|
2016 Q4
|
2.90%
|
$36.25
|
+36.48% (+64,119)
|
|||
|
2016 Q3
|
3.09%
|
$46.01
|
-0.50% (-885)
|
|||
|
2016 Q2
|
3.49%
|
$50.23
|
-0.29% (-505)
|
|||
|
2016 Q1
|
3.90%
|
$53.51
|
+0.12% (+205)
|
|||
|
2015 Q3
|
3.07%
|
$56.46
|
+0.02% (+40)
|
|||
|
2015 Q2
|
2.35%
|
$59.10
|
+0.12% (+205)
|
|||
|
2015 Q1
|
2.33%
|
$62.30
|
+0.18% (+325)
|
|||
|
2014 Q4
|
2.05%
|
$57.51
|
-0.27% (-470)
|
|||
|
2014 Q2
|
1.65%
|
$52.42
|
+0.81% (+1,415)
|
|||
|
2014 Q1
|
1.65%
|
$52.84
|
-0.51% (-900)
|
|||
|
2013 Q4
|
1.25%
|
$40.08
|
+3.74% (+6,355)
|
|||
|
2013 Q3
|
1.29%
|
$37.78
|
+0.19% (+325)
|
|||
|
2013 Q2
|
1.40%
|
$39.20
|
new or own*
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.